41100_2018_184_MOESM3_ESM.zip (1.06 MB)
Additional file 3: of Patency with antiplatelet treatment after vascular access intervention therapy: a retrospective observational study
dataset
posted on 2018-11-07, 05:00 authored by Tomohito Mizuno, Motonobu Nakamura, Nobuhiko Satoh, Hiroyuki Tsukada, Akihiko Matsumoto, Yoshifumi Hamasaki, Haruki Kume, Masaomi NangakuFigure S2. Scaled Schoenfeld residuals for each factor. The residual was estimated as the time-dependent coefficient beta (t) vs. transformed time. The proportional hazards assumption of age was violated (p < 0.001), but that of the other factors was fitted (p > 0.05) (Additional file 2: Table S1). a Age, b Older age, c Sex, d DN, e NS, f CGN, g IgAN, h Other or unknown, i Smoking history, j DM, k Dyslipidemia, l CVD, m IHD, n CHF, o Stroke, p PAD, q RASI, r Statin, s Warfarin, t Antiplatelet agents, u Radiocephalic, v Brachiocephalic (ZIP 1081 kb)